🔗 Visit the ClinicalTrials.gov page for NCT01571024
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial watch: Chemotherapy with immunogenic cell death inducers. | Oncoimmunology | 2013 | 1.31 |
| 2 | Current and future systemic treatment options in metastatic pancreatic cancer. | J Gastrointest Oncol | 2014 | 0.95 |
| 3 | Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future. | J Hematol Oncol | 2015 | 0.91 |
| 4 | Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapy. | Oncologist | 2014 | 0.87 |
| 5 | State of the art biological therapies in pancreatic cancer. | World J Gastrointest Oncol | 2016 | 0.78 |
| 6 | Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies. | World J Gastroenterol | 2016 | 0.77 |
| 7 | Pancreatic cancer from bench to bedside: molecular pathways and treatment options. | Ann Transl Med | 2016 | 0.75 |